JP2016531593A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531593A5 JP2016531593A5 JP2016544355A JP2016544355A JP2016531593A5 JP 2016531593 A5 JP2016531593 A5 JP 2016531593A5 JP 2016544355 A JP2016544355 A JP 2016544355A JP 2016544355 A JP2016544355 A JP 2016544355A JP 2016531593 A5 JP2016531593 A5 JP 2016531593A5
- Authority
- JP
- Japan
- Prior art keywords
- deoxyuridine
- aptamer
- carboxamide
- composition
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091023037 Aptamer Proteins 0.000 claims 43
- 239000000203 mixture Substances 0.000 claims 30
- 238000000034 method Methods 0.000 claims 22
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 18
- 238000012986 modification Methods 0.000 claims 17
- 230000004048 modification Effects 0.000 claims 17
- 150000003857 carboxamides Chemical class 0.000 claims 11
- -1 (N-benzylcarboxamide) -2′-deoxyuridine Chemical compound 0.000 claims 6
- 230000015572 biosynthetic process Effects 0.000 claims 4
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 claims 3
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 claims 2
- 125000004924 2-naphthylethyl group Chemical group C1=C(C=CC2=CC=CC=C12)CC* 0.000 claims 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 2
- 125000005518 carboxamido group Chemical group 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 2
- 230000036963 noncompetitive effect Effects 0.000 claims 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 1
- 150000003230 pyrimidines Chemical class 0.000 claims 1
- 229940113082 thymine Drugs 0.000 claims 1
- 229940035893 uracil Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361881629P | 2013-09-24 | 2013-09-24 | |
| US61/881,629 | 2013-09-24 | ||
| PCT/US2014/057143 WO2015048084A1 (en) | 2013-09-24 | 2014-09-24 | Multiaptamer target detection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531593A JP2016531593A (ja) | 2016-10-13 |
| JP2016531593A5 true JP2016531593A5 (cg-RX-API-DMAC7.html) | 2017-11-02 |
| JP6506768B2 JP6506768B2 (ja) | 2019-04-24 |
Family
ID=52744404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016544355A Active JP6506768B2 (ja) | 2013-09-24 | 2014-09-24 | 多重アプタマー標的の検出 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9926566B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3049523B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6506768B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102348283B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105555957A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014326975B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016005957A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2924987C (cg-RX-API-DMAC7.html) |
| HK (1) | HK1218765A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL244284B (cg-RX-API-DMAC7.html) |
| MX (1) | MX361451B (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201602063UA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015048084A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX361451B (es) | 2013-09-24 | 2018-12-06 | Somalogic Inc | Detección objetivo de múltiples aptámeros. |
| RU2708170C2 (ru) | 2014-11-24 | 2019-12-04 | Сомалоджик, Инк. | Соединения нуклеиновой кислоты для связывания ростового фактора дифференцировки 11 |
| WO2017100441A1 (en) * | 2015-12-08 | 2017-06-15 | Twinstrand Biosciences, Inc. | Improved adapters, methods, and compositions for duplex sequencing |
| TWI733772B (zh) | 2016-03-14 | 2021-07-21 | 美商身體邏輯股份有限公司 | 用於合成吲哚環核鹼基結合物之組成物及方法 |
| WO2017218881A1 (en) * | 2016-06-17 | 2017-12-21 | Proximity Biosciences, Llc | Method for aptamer pair selection |
| US10927380B2 (en) * | 2016-07-01 | 2021-02-23 | Somalogic, Inc. | Oligonucleotides comprising modified nucleosides |
| JP2020514746A (ja) | 2016-12-01 | 2020-05-21 | ノーティラス バイオテクノロジー インコーポレイテッド | タンパク質をアッセイする方法 |
| WO2019103131A1 (ja) * | 2017-11-24 | 2019-05-31 | 国立大学法人 東京大学 | アプタマーの結合部位判別方法、アプタマーペアおよび目的物質からなる三元錯体の解離定数等の測定方法並びに最適なアプタマーペアの選択方法 |
| CA3086915A1 (en) | 2017-12-29 | 2019-07-04 | Sujal M. Patel | Decoding approaches for protein identification |
| US20210247387A1 (en) * | 2018-06-22 | 2021-08-12 | Somalogic, Inc. | Improved proteomic multiplex assays |
| CA3182266A1 (en) | 2020-06-11 | 2021-12-16 | Vadim Lobanov | Methods and systems for computational decoding of biological, chemical, and physical entities |
| CA3203106A1 (en) | 2021-01-20 | 2022-07-28 | Parag Mallick | Systems and methods for biomolecule quantitation |
| US20220227890A1 (en) | 2021-01-21 | 2022-07-21 | Nautilus Biotechnology, Inc. | Systems and methods for biomolecule preparation |
| IL305336B2 (en) | 2021-03-11 | 2025-09-01 | Nautilus Subsidiary Inc | Systems and methods for preserving biomolecules |
| EP4399528A1 (en) | 2021-09-09 | 2024-07-17 | Nautilus Subsidiary, Inc. | Characterization and localization of protein modifications |
| EP4405683A1 (en) | 2021-09-22 | 2024-07-31 | Nautilus Subsidiary, Inc. | Methods and systems for determining polypeptide interactions |
| WO2023081728A1 (en) | 2021-11-03 | 2023-05-11 | Nautilus Biotechnology, Inc. | Systems and methods for surface structuring |
| EP4441503A1 (en) | 2021-11-30 | 2024-10-09 | Nautilus Subsidiary, Inc. | Particle-based isolation of proteins and other analytes |
| CA3245990A1 (en) | 2022-03-29 | 2023-10-05 | Nautilus Subsidiary, Inc. | INTEGRATED NETWORKS FOR SINGLE-ANALYTE PROCESSES |
| EP4515026A1 (en) | 2022-04-25 | 2025-03-05 | Nautilus Subsidiary, Inc. | Systems and methods for assessing and improving the quality of multiplex molecular assays |
| WO2023250364A1 (en) | 2022-06-21 | 2023-12-28 | Nautilus Subsidiary, Inc. | Method for detecting analytes at sites of optically non-resolvable distances |
| WO2024059655A1 (en) | 2022-09-15 | 2024-03-21 | Nautilus Subsidiary, Inc. | Characterizing accessibility of macromolecule structures |
| WO2024073599A1 (en) | 2022-09-29 | 2024-04-04 | Nautilus Subsidiary, Inc. | Preparation of array surfaces for single-analyte processes |
| US20240183858A1 (en) | 2022-11-15 | 2024-06-06 | Nautilus Subsidiary, Inc. | Standard polypeptides |
| US20240192202A1 (en) | 2022-12-09 | 2024-06-13 | Nautilus Subsidiary, Inc. | Fluidic media for single-analtye arrays |
| EP4634285A1 (en) | 2022-12-15 | 2025-10-22 | Nautilus Subsidiary, Inc. | Inhibition of photon phenomena on single molecule arrays |
| US20240241110A1 (en) | 2023-01-12 | 2024-07-18 | Nautilus Subsidiary, Inc. | Characterization of glycans and glycoconjugates |
| EP4689173A1 (en) | 2023-03-24 | 2026-02-11 | Nautilus Subsidiary, Inc. | Improved transfer of nanoparticles to array surfaces |
| WO2024216233A1 (en) | 2023-04-13 | 2024-10-17 | Nautilus Subsidiary, Inc. | Artificial proteins for displaying epitopes |
| US20240394902A1 (en) | 2023-05-24 | 2024-11-28 | Nautilus Subsidiary, Inc. | Systems and methods for machine vision |
| US20250189519A1 (en) | 2023-12-11 | 2025-06-12 | Nautilus Subsidiary, Inc. | Methods and compositions of particle-based arrays |
| US20250205706A1 (en) | 2023-12-20 | 2025-06-26 | Nautilus Subsidiary, Inc. | Fluidic devices for single-analyte assays |
| US20250298016A1 (en) | 2024-03-22 | 2025-09-25 | Nautilus Subsidiary, Inc. | Plasmonic particle systems for single-analyte assays |
| US20250305034A1 (en) | 2024-04-01 | 2025-10-02 | Nautilus Subsidiary, Inc. | Nanostructures for modulation of analyte conformation |
| WO2026073213A1 (en) * | 2024-09-30 | 2026-04-02 | Illumina, Inc. | Protein capture techniques with surface linked aptamers |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001257091A1 (en) * | 2000-04-18 | 2001-10-30 | Gilead Sciences, Inc. | Aptamer based two-site binding assay |
| WO2002026932A2 (en) * | 2000-09-26 | 2002-04-04 | Duke University | Rna aptamers and methods for identifying the same |
| US20070071744A1 (en) * | 2002-06-07 | 2007-03-29 | Gotz Munch | Agents which bind to epitopes of glycoprotein VI |
| US7595160B2 (en) | 2004-01-13 | 2009-09-29 | U.S. Genomics, Inc. | Analyte detection using barcoded polymers |
| US7795009B2 (en) * | 2005-06-15 | 2010-09-14 | Saint Louis University | Three-component biosensors for detecting macromolecules and other analytes |
| US20100035247A1 (en) | 2005-11-04 | 2010-02-11 | U.S. Genomics, Inc. | Heterogeneous Assay of Analytes in Solution Using Polymers |
| US8658670B2 (en) | 2006-09-26 | 2014-02-25 | Crestone, Inc. | Methods and compounds for treatment of clostridium based infection |
| US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| ES3045958T3 (en) * | 2007-07-17 | 2025-12-01 | Somalogic Operating Co Inc | Method for generating aptamers with improved off-rates |
| US20100239682A1 (en) | 2007-09-17 | 2010-09-23 | Antoine Andremont | Colonic delivery of antimicrobial agents |
| US8569252B2 (en) | 2009-04-15 | 2013-10-29 | Postech Academy-Industry Foundation | Nucleolin specific aptamer and use thereof |
| US20110256535A1 (en) | 2010-02-11 | 2011-10-20 | Intelligent Medical Devices, Inc. | Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantification, monitoring, screening and sequencing of clostridium difficile genes encoding toxin b, and/or toxin a and/or binary toxin |
| GB201002627D0 (en) | 2010-02-16 | 2010-03-31 | Loxbridge Res Llp | Aptamer based analyte detection method |
| NZ602618A (en) * | 2010-04-12 | 2013-12-20 | Somalogic Inc | Aptamers to beta-ngf and their use in treating beta-ngf mediated diseases and disorders |
| US8785132B2 (en) * | 2010-04-23 | 2014-07-22 | Postech Academy-Industry Foundation | Aptamer sandwich assays |
| US20150031585A1 (en) | 2011-03-10 | 2015-01-29 | Somalogic, Inc. | Multiaptamer Target Detection |
| WO2012122540A1 (en) | 2011-03-10 | 2012-09-13 | Somalogic, Inc. | Aptamers for clostridium difficile diagnostics |
| AU2012249658A1 (en) * | 2011-04-26 | 2013-05-09 | Regado Biosciences, Inc. | A method for manufacturing pegylated oligonucleotides |
| KR102248900B1 (ko) | 2011-09-30 | 2021-05-07 | 소마로직, 인크. | 심혈관 위험 사건 예측 및 그것의 용도 |
| MX355567B (es) | 2011-12-30 | 2018-04-23 | Quest Diagnostics Invest Inc | Aptameros y metodos de diagnostico para detectar el receptor de egf. |
| MX361451B (es) | 2013-09-24 | 2018-12-06 | Somalogic Inc | Detección objetivo de múltiples aptámeros. |
-
2014
- 2014-09-24 MX MX2016003320A patent/MX361451B/es active IP Right Grant
- 2014-09-24 EP EP14847780.5A patent/EP3049523B1/en active Active
- 2014-09-24 CA CA2924987A patent/CA2924987C/en active Active
- 2014-09-24 JP JP2016544355A patent/JP6506768B2/ja active Active
- 2014-09-24 US US15/023,182 patent/US9926566B2/en active Active
- 2014-09-24 WO PCT/US2014/057143 patent/WO2015048084A1/en not_active Ceased
- 2014-09-24 HK HK16106780.3A patent/HK1218765A1/zh unknown
- 2014-09-24 CN CN201480051210.1A patent/CN105555957A/zh active Pending
- 2014-09-24 AU AU2014326975A patent/AU2014326975B2/en active Active
- 2014-09-24 CN CN202210264586.7A patent/CN114703193A/zh active Pending
- 2014-09-24 SG SG11201602063UA patent/SG11201602063UA/en unknown
- 2014-09-24 KR KR1020167006262A patent/KR102348283B1/ko active Active
- 2014-09-24 BR BR112016005957A patent/BR112016005957A2/pt not_active IP Right Cessation
-
2016
- 2016-02-25 IL IL244284A patent/IL244284B/en active IP Right Grant
-
2018
- 2018-02-13 US US15/895,723 patent/US10392621B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014511686A5 (cg-RX-API-DMAC7.html) | ||
| Janssen et al. | RsmV, a small noncoding regulatory RNA in Pseudomonas aeruginosa that sequesters RsmA and RsmF from target mRNAs | |
| EA201200217A1 (ru) | Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков | |
| JP2015507625A5 (cg-RX-API-DMAC7.html) | ||
| JP2013514797A5 (cg-RX-API-DMAC7.html) | ||
| JP2017002079A5 (cg-RX-API-DMAC7.html) | ||
| JP2016065872A5 (cg-RX-API-DMAC7.html) | ||
| JP2012136542A5 (cg-RX-API-DMAC7.html) | ||
| EA201491180A1 (ru) | 4'-азидо,3'-фторзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гепатита с | |
| MX371440B (es) | Composiciones nucleotidicas modificadas con citidina-5-carboxamida y metodos relacionados con las mismas. | |
| Ye et al. | Remdesivir (GS-5734) impedes enterovirus replication through viral RNA synthesis inhibition | |
| JP2009509548A5 (cg-RX-API-DMAC7.html) | ||
| JP2016116520A5 (cg-RX-API-DMAC7.html) | ||
| JP2012105686A5 (cg-RX-API-DMAC7.html) | ||
| RU2017120536A (ru) | Способы и композиции для модулирования экспрессии аполипопротеина (а) | |
| JP2010227108A5 (cg-RX-API-DMAC7.html) | ||
| MX2016007980A (es) | Acido nucleico que induce acido ribonucleico de interferencia modificado para prevenir una falla en alcanzar el objetivo, y uso del mismo. | |
| JP2014501492A5 (cg-RX-API-DMAC7.html) | ||
| Fajardo Jr et al. | Rotavirus genomic RNA complex forms via specific RNA–RNA interactions: disruption of RNA complex inhibits virus infectivity | |
| JP2021520815A5 (cg-RX-API-DMAC7.html) | ||
| JP2012505657A5 (cg-RX-API-DMAC7.html) | ||
| JP2014513929A5 (cg-RX-API-DMAC7.html) | ||
| Wei et al. | Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time | |
| Jääskeläinen et al. | Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF | |
| Hsu et al. | Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus |